Preliminary Topics
- The role of MALDI-TOF and rtPCR in improving therapy/public health + sequencing as well given the mobile sequencing devices now available
- Epidemiology and antimicrobial resistance
- How to use AMR testing effectively
- Do we need new antibacterials
- Syndromic testing i.e. multiplex PCR targeting multiple targets in a single assay versus single target assays.
- Where are we with smart phones and results reporting?
- Alternatives to antimicrobials where are we at or alternatives to antimicrobials: vaccines, bacteriophages, probiotics....
- Antimicrobial resistance and the microbiome
- Determination and interpretation of clinical breakpoints
- Where are we with Artificial Intelligence in Clinical Microbiology and Infectious Diseases
- Gut microbiome and its relation to antimicrobial therapy